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oronary Perforation
n Inconvenient Complication*
ric Eeckhout, MD, PHD, Rodney De Palma, MD
ausanne, Switzerland
oronary perforation is one of the most challenging and
eared complications of percutaneous coronary intervention
PCI). The angiographic images of a large perforation are
pectacular and are often debated during complication case
eview sessions at interventional cardiology meetings.
herefore, even if most interventional cardiologists have not
een exposed personally, they are perfectly aware of this rare
omplication. Coronary perforation has been classified by
llis et al. (1) in 1994, type III being the most severe form
f perforation. It was originally defined as an active extrav-
sation through a large breach (at least 1 mm) in the
ntegrity of the adventitia of an epicardial artery in the
ericardial space or in a cardiac chamber. This complication
s rare (0.1% to 3.0%), often requires pericardiocentesis for
amponade, as well as combination of interventional tech-
iques to seal the perforation, and occasionally surgical
epair (2). The morbidity and mortality of large perforations
s known to be high.
See page 87
In this issue of JACC: Cardiovascular Interventions, Al-
amee et al. (3) reviewed the incidence, predictors, man-
gement, and clinical outcome of type III perforations
uring PCI in a large tertiary referral center. Over a 16-year
eriod, this complication was noted in 56 of 24,465 con-
ecutive patients undergoing PCI, thus giving a reported
ncidence of 0.23%.
A review of the literature reveals abundant data on
erforation during PCI (1,2). The findings of the current
bservation are in accordance with common knowledge and
rovide some new, added value. Albeit rare, the incidence of
erforation has not decreased over time, probably reflecting
he increased complexity of PCI practice. This complexity is
llustrated by the independent predictors of perforation seen
n the present study: complex coronary anatomy (type B2
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
From the Cardiology Division, Centre Hospitalier Universitaire Vaudois, Lau-d
anne, Switzerland. The authors have reported that they have no relationships to
isclose.nd C lesions), chronic total occlusion, rotational atherec-
omy, and intravascular ultrasound use. These predictors
ave all been identified previously (2,4). The highest risk
as related to intravascular ultrasound use, reflecting PCI in
omplex lesion subsets, according to the investigators. They
lso speculate further in this context, on the role of higher
alloon pressures or larger balloon sizes to optimize the
ngiographic result according to pre-defined intravascular
ltrasound criteria. This is perfectly in line with the most
ommon cause of perforation in the present study: compli-
nt or noncompliant balloons and the stent-balloon delivery
ystem. Interestingly, the second most frequent cause of
erforation in the present study was guidewire exit (10
atients). Guidewire exit perforation usually causes “rela-
ively small leaks” in the distal coronary bed or a side branch
nd is nowadays mostly successfully treated by coiling or
article embolization technology. It is therefore unclear why
uidewire exit leads so frequently to type III perforation in
his cohort.
Concomitant glycoprotein IIb/IIIa antagonist use in-
reased dramatically the complication rate and decreased,
espite applying different treatment modalities, hemostasis
uccess. Even if the number of patients is too small to draw
ny firm conclusions, it makes common sense to pay
articular attention to perforations in these patients, treat-
ng them more aggressively and reversing any antiplatelet
ctivity if possible. It is known that guidewire exit and
lycoprotein IIb/IIIa antagonist do not sit well with each
ther. Although enough information is not available in the
resent article, if frequently associated, this may possibly
xplain the high prevalence of guidewire exit as a cause of
ype III perforation in this study.
The treatment of a type III perforation remains a chal-
enge for every catheterization laboratory team. It integrates
ontinuous assessment of the hemodynamic status and the
eed for appropriate treatment of tamponade if needed, as
ell as an immediate attempt to seal the perforation. Both
onditions are closely interrelated and failure to treat either
ill affect the immediate prognosis of the patient. Place-
ent of a pericardial drain in the emergency setting is
ifficult particularly if tamponade is caused by the acute
ccumulation of a relatively modest amount of blood.
chocardiographic and fluoroscopic guidance are of critical
mportance in this situation. Any additional complication
ue to inadvertent myocardial puncture will further com-
romise the patient’s outcome. The investigators observe
urrently that hemostasis often requires multiple treatment
odalities: prolonged balloon inflation, implantation of a
tandard or covered stent, coil embolization, and/or surgical
epair. Even if precise data are lacking, it seems that most
atients could be treated by a combination of prolonged
alloon inflation and implantation of a covered stent. This
s important new information that is highlighted by a
ramatic increase in procedural success and a clear reduction
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97n in-hospital morbidity and mortality during this 16-year
bservation period. Without doubt, covered stents (84.6%
n the present series) have the highest potential to seal large
erforations. They are probably responsible in large part for
he increased success rate in managing large perforation.
here are, however, clear downsides. First, covered stents
re bulky and proper stent delivery may be difficult or
mpossible. A helpful technique not described in the current
rticle is the “double guiding catheter” technique. This
onsists of prolonged or intermittent (in patients with
xtensive ischemia) balloon inflation through the initial
uiding catheter while preparing femoral access for an 8-F
uiding approach. Upon balloon deflation through the
nitial guiding catheter, a guidewire is advanced through the
econd guiding catheter distal to the site of perforation to
eliver the covered stent. The advantage of the technique is
hat temporary sealing of the perforation can occur while
imultaneously preparing better support for stent delivery.
he paper by Al-Lamee et al. (3) yields another important
essage and a second drawback of polytetrafluoroethylene-
overed stents, in particular. The incidence of definitive
tent thrombosis was 8.6% and only occurred after place-
ent of polytetrafluoroethylene-covered stents. This is
igher than with metallic noncovered stents suggesting a
igher thrombogenicity of this platform. The role of pos-
ible suboptimal stent expansion of this double-layer metal-
ic device is unknown. Furthermore, the type of long-term
ntiplatelet strategy may also have been important. Prasug-
el, because of its lack of intrinsic resistance, might be
onsidered as the thienopyridine of choice, although there
re no data available.
The present article provides an algorithm for managing
ype III perforation. It is straightforward and comprehen-
ive. The only uncertainty concerns the role of heparin
eversal with protamine sulfate. Opinions clearly diverge on
his subject. On the one hand, it may assist in sealing a
erforation, but on the other, bleeding may persist and
rolonged balloon inflation and simultaneous heparin rever-
al may lead to proximal vessel thrombosis. It is our belief
hat no universal guidance can be given based on the data
vailable. Decisions should be pragmatic and individualized
ependent on the hemodynamic status of the patient,
oncomitant IIb/III antagonist use, activated clotting time,
nd the duration of prolonged balloon inflation.
One particular form of type III perforation is termedavity spilling (cardiac chamber, coronary sinus). Appar- mntly, this complication was not encountered in this obser-
ational study. In general, management should be less
ggressive because of the lack of associated acute hemody-
amic compromise.
A large type III perforation is an inconvenient complica-
ion. In-hospital mortality was high at 14.8% and the rate of
yocardial infarction was 42.9%. This proportion increased
urther during follow-up. Even in the experienced hands of
hese operators, the reported results are not better than what
an be found in literature, indicating a need for better
herapeutic devices.
In conclusion, this article has drawn our attention again
n a dramatic but rare complication of PCI: type III
erforation. The key messages are as follows. 1) Concom-
tant IIb/IIIa antagonist use increases the complications rate
ubstantially and diminishes the ability to seal a perforation
uccessfully. Its effect should be reverted if possible.
) Polytetrafluoroethylene-covered stents have the greatest
otential to seal type III perforations and probably explain
ncreasing procedural success over the period observed.
owever, these potentially “life-saving” devices are defi-
itely more thrombogenic. The investigators’ conclusion is
pposite: “This complication is still associated with poor
dverse outcomes and there remains a need for improved
echnology in order to treat this dreaded complication.”
eprint requests and correspondence: Dr. Eric Eeckhout, Car-
iology Division, Centre Hospitalier Universitaire Vaudois, Rue
u Bugnon 46, 1011 Lausanne, Switzerland. E-mail: eric.
eckhout@chuv.ch.
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